These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10870645)

  • 21. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
    Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
    Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection.
    Wu S; Zhou X; Yang H; Yin J; Cai C; Zheng F
    Clin Chem Lab Med; 2009; 47(2):159-64. PubMed ID: 19191721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease.
    Newsome PN; Beldon I; Moussa Y; Delahooke TE; Poulopoulos G; Hayes PC; Plevris JN
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1295-301. PubMed ID: 11012474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues.
    Kitagawa Y; Iwai M; Muramatsu A; Tanaka S; Mori T; Harada Y; Okanoue T; Kashima K
    Histopathology; 2002 May; 40(5):472-9. PubMed ID: 12010368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma.
    Hamdy K; Al Swaff R; Hussein HA; Gamal M
    J Endocrinol Invest; 2015 Nov; 38(11):1225-31. PubMed ID: 26359143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Glycomics-Based Test Predicts the Development of Hepatocellular Carcinoma in Cirrhosis.
    Verhelst X; Vanderschaeghe D; Castéra L; Raes T; Geerts A; Francoz C; Colman R; Durand F; Callewaert N; Van Vlierberghe H
    Clin Cancer Res; 2017 Jun; 23(11):2750-2758. PubMed ID: 27986746
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma.
    Murawaki Y; Yamamoto H; Kawasaki H; Shima H
    Clin Chim Acta; 1993 Sep; 218(1):47-58. PubMed ID: 8299219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.
    Soresi M; Giannitrapani L; D'Antona F; Florena AM; La Spada E; Terranova A; Cervello M; D'Alessandro N; Montalto G
    World J Gastroenterol; 2006 Apr; 12(16):2563-8. PubMed ID: 16688802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Bcl-2 and TGF-beta1 levels in patients with chronic hepatitis C, liver cirrhosis and hepatocellular carcinoma.
    Ali MA; Koura BA; el-Mashad N; Zaghloul MH
    Egypt J Immunol; 2004; 11(1):83-90. PubMed ID: 15724390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum endocan as a survival predictor for patients with liver cirrhosis.
    Toshikuni N; Ozaki K; George J; Tsutsumi M
    Can J Gastroenterol Hepatol; 2015; 29(8):427-30. PubMed ID: 26669300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma.
    Jodo S; Kobayashi S; Nakajima Y; Matsunaga T; Nakayama N; Ogura N; Kayagaki N; Okumura K; Koike T
    Clin Exp Immunol; 1998 May; 112(2):166-71. PubMed ID: 9649177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokinome profile evaluation in patients with hepatitis C virus infection.
    Capone F; Guerriero E; Colonna G; Maio P; Mangia A; Castello G; Costantini S
    World J Gastroenterol; 2014 Jul; 20(28):9261-9. PubMed ID: 25071319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intercellular adhesion molecule-1 release from human hepatocellular carcinoma.
    Hyodo I; Jinno K; Tanimizu M; Doi T; Nishikawa Y; Hosokawa Y; Moriwaki S
    Cancer Detect Prev; 1996; 20(4):308-15. PubMed ID: 8818391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease.
    Bamias G; Gizis M; Delladetsima I; Laoudi E; Siakavellas SI; Koutsounas I; Kaltsa G; Vlachogiannakos J; Vafiadis-Zouboulis I; Daikos GL; Papatheodoridis GV; Ladas SD
    Can J Gastroenterol Hepatol; 2016; 2016():2637010. PubMed ID: 27595094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection.
    Tsai IT; Wang CP; Yu TH; Lu YC; Lin CW; Lu LF; Wu CC; Chung FM; Lee YJ; Hung WC; Hsu CC
    Cytokine; 2017 Feb; 90():54-59. PubMed ID: 27770715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.
    Marusawa H; Osaki Y; Kimura T; Ito K; Yamashita Y; Eguchi T; Kudo M; Yamamoto Y; Kojima H; Seno H; Moriyasu F; Chiba T
    Gut; 1999 Aug; 45(2):284-8. PubMed ID: 10403743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
    Bruix J; Barrera JM; Calvet X; Ercilla G; Costa J; Sanchez-Tapias JM; Ventura M; Vall M; Bruguera M; Bru C
    Lancet; 1989 Oct; 2(8670):1004-6. PubMed ID: 2572739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.